Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

263 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical benefit of early treatment with bone-modifying agents for preventing skeletal-related events in patients with genitourinary cancer with bone metastasis: A multi-institutional retrospective study.
Owari T, Miyake M, Nakai Y, Hori S, Tomizawa M, Ichikawa K, Shimizu T, Iida K, Samma S, Iemura Y, Momose H, Omori C, Otani T, Kuwada M, Hirao S, Oyama N, Nakagawa Y, Hayashi Y, Tanaka N, Fujimoto K. Owari T, et al. Among authors: momose h. Int J Urol. 2019 Jun;26(6):630-637. doi: 10.1111/iju.13939. Epub 2019 Mar 18. Int J Urol. 2019. PMID: 30883931
Neoadjuvant therapy for locally invasive bladder cancer.
Okajima E, Ozono S, Hirao Y, Babaya K, Aoyama H, Maruyama Y, Samma S, Iwai A, Momose H. Okajima E, et al. Among authors: momose h. Urol Int. 1989;44(6):332-7. doi: 10.1159/000281536. Urol Int. 1989. PMID: 2483004 Clinical Trial.
Sequential changes in stem cell markers in peripheral blood and leukapheresis samples after injections of recombinant human granulocyte colony-stimulating factor in patients with urogenital malignant solid tumors: a preliminary study.
Samma S, Momose H, Ozono S, Hirao Y, Okajima E, Morii T, Nishikawa K, Shimoyama T, Fujimura Y. Samma S, et al. Among authors: momose h. Jpn J Clin Oncol. 1994 Oct;24(5):269-74. Jpn J Clin Oncol. 1994. PMID: 7526017 Clinical Trial.
[Intra-arterial chemotherapy for invasive bladder cancer].
Ozono S, Kim SC, Takashima K, Tani Y, Okajima E, Hirao Y, Maruyama Y, Iwai A, Samma S, Momose H. Ozono S, et al. Among authors: momose h. Hinyokika Kiyo. 1999 Feb;45(2):133-7. Hinyokika Kiyo. 1999. PMID: 10212788 Free article. Clinical Trial. Japanese.
The primary therapy chosen for patients with localized prostate cancer between the university hospital and its affiliated hospitals in Nara Uro-Oncological Research Group registration.
Tanaka N, Fujimoto K, Hirayama A, Samma S, Momose H, Kaneko Y, Haramoto M, Hayashi Y, Nakagawa Y, Otani T, Watanabe S, Hirao Y. Tanaka N, et al. Among authors: momose h. BMC Urol. 2011 Apr 27;11:6. doi: 10.1186/1471-2490-11-6. BMC Urol. 2011. PMID: 21524283 Free PMC article.
The diagnostic utility of retroperitoneoscopic tissue biopsy for unresectable retroperitoneal lesions excluding urogenital cancers.
Miyake M, Fukui S, Gotoh D, Matsumura Y, Samma S, Matsumoto Y, Momose H, Hori S, Watanabe S, Owari T, Morizawa Y, Itami Y, Nakai Y, Inoue T, Anai S, Torimoto K, Aoki K, Tanaka N, Fujimoto K. Miyake M, et al. Among authors: momose h. World J Surg Oncol. 2019 Feb 18;17(1):35. doi: 10.1186/s12957-019-1581-0. World J Surg Oncol. 2019. PMID: 30777073 Free PMC article.
External validation of a genitourinary cancer-specific prognostic scoring system to predict survival for patients with bone metastasis (modified B-FOM scoring model): Comparison with other scoring models in terms of accuracy.
Owari T, Miyake M, Nakai Y, Tanaka N, Itami Y, Hirao S, Momose H, Nakagawa Y, Iida K, Maesaka F, Shimizu T, Iemura Y, Matsumoto Y, Kuwada M, Otani T, Otsuka K, Okajima E, Hosokawa Y, Okamura R, Fujimoto K. Owari T, et al. Among authors: momose h. J Bone Oncol. 2020 Dec 13;26:100344. doi: 10.1016/j.jbo.2020.100344. eCollection 2021 Feb. J Bone Oncol. 2020. PMID: 33384916 Free PMC article.
263 results